Importantly, a clear increase was observed in FRDA fibroblasts transfected with hFXN -expressing construct that raised mFXN to levels higher than those in control fibroblasts from healthy donors, further confirming that the maturation machinery can process more than endogenous levels of FXN in an FRDA disease background (Fig. 1B). This evidence concerns the gene FXN and Friedreich ataxia.